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Abstract 
To assess the influence on short- and long-term survival of haemodynamic variables measured after acute myocardial 
infarction, a IO-year prospective follow-up study was undertaken. A total of 304 patients (259 males, 45 females) 
discharged from hospital after myocardial infarction and under 66 years of age were studied. Haemodynamic variables 
measured shortly after admittance included pulmonary wedge pressure, mixed venous oxygen saturation, blood pres- 
sure and heart rate. In the analysis, adjustments were made for differences in age, gender, clinical parameters and car- 
diovascular risk factors. Pulmonary wedge pressure was found to be a strong and independent predictor of both 
short-term and long-term survival. A gradual increase of the IO-year mortality risk with elevated wedge pressure could 
be demonstrated (relative risk, l.O9/mmHg; 95% confidence interval, I .04- I. 15). Relative risks of patients in the three 
highest categories of wedge pressure, 12-15 mmHg, 15-19 mmHg and 19 mmHg and higher, compared with patients 
in the lowest category, lower than 12 mmHg, were 2.25 (95% CI, I. 11-4.55). 2.43 (95% Cl, 1.20-4.92) and 2.57 (95% 
CI, 1.04-6.37), respectively. The other measured haemodynamic variables were found to be associated with short-term 
mortality only. In conclusion, haemodynamic measurements after myocardial infarction are of prognostic importance 
after discharge. A single measurement of an elevated wedge pressure in particular unfavourably influenced both short- 
term and long-term survival. 
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1. Introduction 
In recent years, the beneficial effects associated 
with the use of Swan-Ganz catheterisation in 
acute myocardial infarction on selected patient 
outcomes, including in-hospital mortality and 
average hospital stay, have been debated [ 1,2]. 
However. the use of the catheterisation of the 
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pulmonary artery may provide prognostic infor- 
mation [3-51. Assessment of factors which affect 
the prognosis of individual patients after myocar- 
dial infarction is potentially useful in patient man- 
agement, design of clinical trials of therapy and 
elucidation of the mechanisms leading to death 
after infarction [6]. 
Previous studies demonstrated the role of 
several haemodynamic variables measured early 
after acute myocardial infarction on subsequent 
mortality [7-91. In particular, an elevated wedge 
pressure was associated with an increased mort- 
ality. In these reports, however, the prognostic 
importance of the haemodynamic variables was 
evaluated within a limited follow-up period. The 
influence of these variables on long-term survival 
remains unknown. Furthermore. most published 
studies failed to adjust for differences in the other 
prognostic factors, by using multivariate statistical 
techniques, and thus the independent role of the 
haemodynamic measurements on survival was not 
reported. 
Since 1978, the Zuiderziekenhuis Hospital in 
Rotterdam routinely collects data on early 
haemodynamic variables, clinical parameters, and 
cardiovascular risk factors of patients discharged 
alive after a myocardial infarction. This enabled us 
to assess the independent long-term prognostic 
importance of haemodynamic variables. 
2. Patients and methods 
2.1. Patients 
All patients discharged alive after a diagnosis of 
acute myocardial infarction from the Zuider- 
ziekenhuis Hospital, Rotterdam between January 
1978 and December 1980, and under 66 years of 
age, were included in the present study, as des- 
cribed previously [lo]. 
The diagnosis acute myocardial infarction was 
based upon at least two of the following criteria 
[l 11: (1) a recent positive clinical history of chest 
pain up to a maximum of 12 h before admission; 
(2) characteristic changes in the electrocar- 
diogram; (3) peak elevation, i.e. a maximum 
recorded level, of serum enzymes (CPK, SGOT) of 
at least 1.5 times the upper limit of normal. 
Follow-up data were obtained from official 
death records and community population regis- 
ters, indicating whether or not the patients were 
still alive and if not, the date of death. Information 
on the vital status up to 5 years after discharge was 
available for all patients. Follow-up data of 302 
patients (99%) were available up to 10 years after 
discharge. 
2.2. Measurements 
Of the 304 survivors at hospital discharge, 262 
patients (86%) had a 7F Swan-Ganz balloon tip- 
ped catheter inserted into the pulmonary artery 
immediately after admission [ 121. The catheters 
were inserted percutaneously into the antecubital 
vein or via subclavian puncture, without need of 
fluoroscopy, by trained medical staff. Pressures 
were recorded by means of strain gauge trans- 
ducers. The zero level was 5 cm below the sternum 
in the supine position. Mixed venous oxygen satur- 
ation was determined from a l-ml blood sample 
drawn from the pulmonary artery. Blood pressure 
was measured with a random zero sphygmomano- 
meter. The heart rate was read from the digital 
display of the electrocardiographic monitor. 
Serum total cholesterol concentration was deter- 
mined by an enzymatic procedure [ 131, approx- 
imately 6 weeks after discharge. Information on a 
history of hypertension, smoking habits, previous 
infarction, and diabetes mellitus was collected dur- 
ing an interview, as soon as possible after hospital 
admittance. History of hypertension was defined 
as a systolic blood pressure of at least 160 mmHg 
and/or a diastolic blood pressure of at least 95 
mmHg, measured on at least two occasions before 
admittance, or when patients were currently taking 
antihypertensive medication for hypertension. 
Patients were classified as being diabetic only if 
anti-diabetic drug therapy had been initiated prior 
to admittance. Patients were classified as smokers 
if they had regularly smoked at least one cigarette, 
cigar or pipe per day in the 3 months before 
admission. 
2.3. Data anal_vsis 
Differences between group means were tested by 
two-tailed Student’s t-test. A x’ statistic was 
calculated to test differences between proportions. 
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To assess the influence of haemodynamic variables 
on short-term and long-term survival, the follow- 
up period was divided into three non-overlapping 
time intervals: up to 1 year, from 1 year to 5 years 
and from 5 to 10 years. Differences in haemo- 
dynamic variables between survivors and non- 
survivors were adjusted for differences in age (con- 
tinuous variable) and gender by analysis of 
covariance. Survival functions were calculated, 
using the Kaplan-Meier product limit method 
[14]. The Mantel-Cox (or log-rank) test was ap- 
plied to evaluate the differences between survival 
functions. Statistical significance was defined as a 
P value of less than 0.05. 
Multivariate analysis was performed by fitting 
Cox’s proportional hazards model [ 151. All 
haemodynamic variables were included separately 
as continuous variables. Odds ratios, which may 
be interpreted as relative risks (RR), with 95% 
confidence intervals (95% CI) were calculated. Pul- 
Table I 
Characteristics of 304 patients discharged alive after acute 
myocardial infarction 
Characteristic (unit) 
(S.D.)b 
n” or ‘I/u 
mean 
S.D 
Male 304 85 
Female 304 15 
Mean (years) age 304 55 7.2 
Myocardial infarction 
Anterior location 304 41 
Inferior location 304 52 
Non-Q-infarction 304 I2 
Previous infarction 304 23 
Peak CPK level (I.U./l) 298 818 I55 
Haemodynamic variables 
Heart rate (beats/min) 294 75 IY 
Systolic blood pressure 296 I35 29 
(mmHg) 
Diastolic blood pressure 296 83 I6 
tmmHg) 
Mixed venous oxygen 262 68 5.7 
saturation (‘%) 
Wedge pressure (mmHg) 261 12 4.9 
Cholesterol (mmol/l) 271 6.7 1.7 
History of hypertension 293 41 
History of smoking 295 74 
Diabetes mellitus 262 6 
%I, number of patients in whom the characteristic was 
measured. 
monary wedge pressure was also included as a 
categorized variable, with calculation of the rela- 
tive risks of IO-year mortality. In the multivariate 
analysis, adjustments were made for differences in 
age (continuous variable), gender. localisation of 
infarction (anterior vs. non-anterior), previous 
infarction, diabetes mellitus, cholesterol (continu- 
ous variable), history of hypertension and smoking 
habits prior to infarction. 
Calculation of the survival curve of the general 
population, matched for age, sex and year of 
observation, was based upon the actual death rates 
in the Dutch population, provided by the Central 
Bureau of Statistics on a yearly basis [16]. 
3. Results 
Basic characteristics of the study population are 
summarized in Table 1 
Among the 304 patients the 1-, 5- and IO-year 
cumulative mortality was 6.5X, 18.4% and 35.5% 
respectively. The survival curve for the 304 pati- 
ents is depicted in Fig. 1. During the study period, 
the yearly average mortality of the general Dutch 
population, matched for age and sex, was 1.6% 
(ranging from 1.1% to 2.2%). 
In Table 2, the initial haemodynamic variables 
of survivors and non-survivors within each of the 
% survival 
loo- 
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Fig. I. Surwval curves of 304 patients discharged alive after 
myocardial infarction (dashed line) and the general Dutch pop- 
ulation. matched for age. gender and year of observation (solid 
line). 
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Table 2 
Comparison of initial haemodynamic variables of patients discharged alive after an acute myocardial infarction. between survivors 
and non-survivors in each of the time intervals” 
Time interval nb Systolic blood Diastolic blood Heart rate 
pressure (mmHg) pressure (mmHg) (beatsimin) 
Mean S.E.C Mean SE. Mean SE. 
First year 
Survivors 284 136 1.7 83 I.0 74 1.1 
Non-survivors 20 121 6.4 79 3.7 86 4.2 
P value <0.05 NSd < 0.005 
1-5 years 
Survivors 248 136 1.8 83 I.0 74 1.2 
Non-survivors 36 134 5.0 82 2.8 76 3.3 
P value NS NS NS 
5-10 years 
Survivors 194 136 2.0 83 1.2 74 1.3 
Non-survivors 52 136 4.0 83 2.3 76 2.6 
P value NS NS NS 
“Adjusted for differences in age and gender. 
bCorresponds to the total number of survivors and non-survivors in each time interval. 
‘S.E., standard error. 
dNS not statistically significant. 
Wedge pressure Venous saturation 
(mmHg) (“/u) 
Mean SE. Mean SE. 
I2 0.3 68 0.4 
17 I.1 65 1.3 
<O.OOOl < 0.05 
II 0.3 68 0.4 
14 0.8 67 1.0 
<O.Ol NS 
II 0.3 68 0.4 
13 0.7 67 0.8 
< 0.005 NS 
time intervals are compared. With the exception of 
diastolic blood pressure, all measured haemodyn- 
amic parameters were significant predictors of l- 
year survival. An elevated wedge pressure was the 
only haemodynamic variable which remained a 
strong indicator of increased mortality l-5, and 
5-10 years after discharge. 
The multivariate survival analysis showed that 
after adjusting for differences in age, gender, local- 
Fig. 2. Kaplan-Meier survival curves of patients after myocar- 
dial infarction, with a pulmonary wedge pressure < 12 mmHg 
(solid line), 12-15 mmHg (n). 15-19 mmHg (+), and 219 
mmHg (dashed line) (P < 0.001) 
isation of infarction, diabetes mellitus, cholesterol 
level, history of hypertension and smoking habits 
prior to infarction, a I-mmHg increase of the pul- 
monary wedge pressure was associated with a 9% 
increase in lo-year mortality (RR, l.O9/mmHg; 
95% confidence interval, 1.04- 1.15). The corres- 
ponding relative risks in the three non-overlapping 
time intervals, 0- 1, l-5, and 5- 10 years, were 
1 .SO/mmHg (95% CI, l.lO-2.04), 1 .OS/mmHg 
Table 3 
Relative risks of IO-year mortality after discharge after acute 
myocardial infarction, of patients in different categories of pul- 
monary wedge pressure” 
Wedge pressure nb (%) Relative 95% Confidence 
(mmHg) risk interval 
<I2 134 (51) I .oc 
r12and ~15 49 (19) 2.25 1.1 I-4.55 
215 and <I9 50 (19) 2.43 1.20-4.92 
2 19 28 (II) 2.57 1.04-6.37 
“Adjusted for differences in age, gender, previous infarction, 
localisation of infarction, diabetes mellitus, cholesterol level, 
history of hypertension and smoking habits prior to infarction. 
bn corresponds to the number of patients in each category. 
‘Reference category. 
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(95”% CI, 0.95-1.18) and l.lO/mmHg (95% CI, 
1.02- 1.18), respectively. An elevated heart rate 
had a statistically significant influence on l-year 
mortality only (relative risk, l.O5/beat per min; 
95%~ CI, 1 .Ol- 1.08). The other haemodynamic var- 
iables were not statistically significant predictors 
of mortality in the multivariate analysis. 
To study pulmonary wedge pressure in more 
detail, wedge pressure was divided into 4 catego- 
ries: lower than 12 mmHg, 12-15 mmHg, 15-19 
mmHg, and 19 mmHg and higher. The unadjusted 
survival curves of patients in these categories are 
depicted in Fig. 2. Survival of patients in the three 
highest categories of wedge pressure was com- 
pared with survival of patients in the lowest cate- 
gory. Results of multivariate analysis after 10 
years of follow-up are shown in Table 3. Com- 
pared with patients in the lowest category ( < 12 
mmHg), a significant increase of IO-year mortality 
is demonstrated for all three other categories of 
pulmonary wedge pressure level. 
No J- or U-shaped relationship between pulmo- 
nary wedge pressure and mortality could be 
demonstrated. 
4. Discussion 
This study demonstrates that a single measure- 
ment of an elevated pulmonary wedge pressure 
after acute myocardial infarction may be a strong 
and independent predictor of both short-term and 
long-term mortality. Of the other measured 
haemodynamic variables, systolic blood pressure, 
heart rate and mixed venous oxygen saturation 
showed only a weak association with short-term 
survival only. 
Although clinical signs of pulmonary congestion 
begin at a level of approximately 18 mmHg [ 171, 
the generally accepted upper limit of normal is 12 
mmHg [ 181. Some previous reports made a dis- 
tinction between patients with a wedge pressure 
greater than or equal to 15 mmHg and a wedge 
pressure lower than 15 mmHg [8,19]. We categor- 
ized the wedge pressure level in four groups: lower 
than 12 mmHg, 12- 15 mmHg, 15- 19 mmHg, and 
19 mmHg and higher. A significant increase of lo- 
year mortality could be demonstrated in all three 
groups, compared with those patients with wedge 
pressure below 12 mmHg. 
Previous studies demonstrated a significant dif- 
ference of haemodynamic variables measured 
early after myocardial infarction between sur- 
vivors and non-survivors of the hospital period 
[4,8,9], a few months [9], 2 years [5] and 4 years [7] 
after discharge. Wolffenbuttel et al. demonstrated 
a strong association between an elevated pulmo- 
nary wedge pressure and increased mortality [7]. 
Whereas previous studies demonstrated the pre- 
dictive value within a maximum follow-up period 
of 4 years, we were able to demonstrate prognostic 
importance ven after a lo-year follow-up period. 
To our knowledge this report is the first to evalu- 
ate long-term prognostic value of haemodynamic 
variables. 
Every patient in the early phase of an acute 
myocardial infarction has to be regarded as poten- 
tially haemodynamically unstable. Pulmonary 
congestion at the time of an acute myocardial in- 
farction is associated with a poor prognosis [20]. 
Early recognition and differentiation of the under- 
lying pathology of the pump failure is essential for 
prompt, appropriate treatment [21]. Methods for 
classifying patients with acute myocardial infarc- 
tion, such as proposed by Killip and Kimball [22], 
have been developed in an effort to define clinic- 
ally relevant syndromes. This method is readily 
used at the bedside and has some therapeutic 
relevance, but the criteria are vague in several 
respects [23]. Moreover, both clinical signs and the 
classical chest roentgenogram have limitations in 
indicating unfavourable haemodynamic hanges 
after acute myocardial infarction [24,25]. Swan- 
Ganz catheterisation demonstrates heart failure in 
absence of clinical or radiological characteristics 
[8], and facilitates an objective assessment of the 
level of cardiac performance. For this reason 
Swan-Ganz catheterisation has been widely used 
in the acute phase of myocardial infarction. Our 
study, however, indicates that the measurements 
during Swan-Ganz catheterisation may be of 
importance long after the acute phase. 
Our study has several limitations. During the 
period January 1978 to December 1980 all patients 
admitted with diagnosis of acute myocardial in- 
farction to Zuiderziekenhuis Hospital, Rotterdam, 
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routinely received Swan-Ganz catheterisation. In 
15% of the hospital survivors however, Swan- 
Ganz catheterisation was not performed, or per- 
formed more than 24 h after admission, mainly 
because of an uncertain diagnosis in the initial 
phase. To evaluate whether this may have influ- 
enced our findings, the survival curves of patients 
with and without catheterisation were compared. 
No difference of the survival curves was demon- 
strated (P > 0.1). Only the mean peak CPK level 
was significantly higher in patients receiving 
catheterisation. 
The time elapsed from onset of symptoms of 
myocardial infarction to Swan-Ganz catheterisa- 
tion could not be calculated in this study since no 
relevant data were collected. Furthermore, be- 
cause only a single measurement of the haemo- 
dynamic variables was available, regression to the 
mean or other sources of variability could have 
diluted the observed associations. A decrease in 
wedge pressure during the first hours after myo- 
cardial infarction was reported in several studies 
[5,26]. The mean of multiple measurements of the 
pulmonary wedge pressure may be an even stron- 
ger indicator of future mortality. Also, varying 
delay times before recordings of first haemodyn- 
amic measurements could have distorted our 
findings. 
We did not identify right ventricular (RV) in- 
farction. RV infarction is associated with a high 
mortality, although haemodynamic measurements 
may be normal (8,271. We presume that if patients 
with RV infarction were excluded, the association 
of an elevated pulmonary wedge pressure with in- 
creased mortality would have been even stronger. 
However, the clinical incidence of RV infarction 
has been estimated to be low [28] and thus the 
effect would have been minimal. Furthermore, we 
did not identify mitral insufficiency. Mitral insufli- 
ciency may cause an artificial elevated wedge pres- 
sure [29] and is associated with diminished 
long-term survival [30]. Hence, a part of the as- 
sociation between an elevated wedge pressure and 
increased mortality could be caused by mitral in- 
sufficiency. Finally, no data on medication ad- 
ministered prior to infarction were available. Drug 
treatment could have influenced the early 
measurements, for instance beta blockers affecting 
the heart rate. 
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Previous studies demonstrated the safety of 
Swan-Ganz catheterisation [31]. In current prac- 
tice however, many patients with acute myocardial 
infarction receive thrombolytic therapy [32]. These 
patients are at high risk of developing haemor- 
rhagic complications [33,34], and more than 70% 
of bleeding episodes occur at catheterisation of 
vascular puncture sites [35]. Venous and arterial 
puncture should be kept to an absolute minimum 
in patients treated with thrombolytic agents and 
should be cared for meticulously thereafter [36]. 
For this reason many physicians are reluctant 
nowadays to insert a Swan-Ganz catheter in pa- 
tients on thrombolytic therapy. The question, of 
course is whether or not the diagnostic and pro- 
gnostic information from the Swan-Ganz 
catheterisation justifies the potential bleeding risk 
in the acute phase. However, a substantial propor- 
tion of patients with acute myocardial infarction 
do not receive thrombolytic therapy [37,38]. 
Furthermore, after the introduction of throm- 
bolytic therapy, approximately 10% of the patients 
with myocardial infarction received Swan-Ganz 
catheterisation [39]. Moreover, some reports sug- 
gest that haemodynamic measurements performed 
48 h or even longer after acute myocardial infarc- 
tion might be the best reflection of haemodynamic 
changes [40]. At that time the bleeding risk from 
thrombolytic agents is less serious. 
We conclude that in patients with acute myocar- 
dial infarction, early haemodynamic recordings 
provide short-term prognostic information. 
Moreover, the pulmonary wedge pressure level, 
measured shortly after acute myocardial infarc- 
tion, remains a strong and independent prognostic 
factor for a period of at least 10 years after infarc- 
tion, Thus, Swan-Ganz catheterisation after acute 
myocardial infarction is not only useful in immedi- 
ate patient management, but also provides pro- 
gnostic information for years after discharge. 
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